▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] Korean pharmaceutical company Dong-A ST announced on Jan. 14 that it aims to expand its ethical drug division by stepping up sales of Suganon. “We are hoping for Suganon’s sales to...
[THE INVESTOR] Korean bio company Tium Bio announced on Jan. 11 that it has signed an exclusive license agreement with Chiesi Group, an international research-focused health care company. Tium Bio ...
[THE INVESTOR] Korean botulinum toxin manufacturer Hugel has acquired a patent here for its technology to develop patch-type BTX, taking an innovative approach for an alternative to the convention...
[THE INVESTOR] Korean drug development startup Vivozon plans to be listed on the second-tier KOSDAQ market this year, according to industry sources on Jan. 8. “It is true that we are aiming to go p...
[THE INVESTOR] Korean firm Handok Pharmaceuticals said on Jan. 8 that it has entered a US$25 million preferred stock purchase agreement with local player Genexine to invest in an American drug maker...
[THE INVESTOR] Samsung Bioepis said on Jan. 7 it is entering the Chinese market through a biosimilar commercialization partnership with 3SBio. This will be the third overseas destination for the dr...
[THE INVESTOR] Korean biotech firm Hugel has solicited the services of global consulting firm McKinsey & Co. on declining profits, according to sources on Jan. 4. “Hugel has started receiving consu...
[THE INVESTOR] Korean drug maker Yuhan said on Dec. 7 that it has signed a US$785 million deal with US biotechnology firm Gilead Sciences to export its new liver disease treatment technology. Th...
[THE INVESTOR] Korea’s leading biosimilar firm Celltrion will establish a direct sales network for its drugs worldwide, namely for its Remsima SC -- a subcutaneous version of Remsima – in an effort ...
[THE INVESTOR] Global pharmaceutical giant Bristol-Myers Squibb is set to take over US-based Celgene for a record-breaking US$74 billion, according to a Bloomberg report on Dec. 4. BMS has valued C...
[THE INVESTOR] Celltrion Healthcare, an affiliate of one of Korea’s leading biopharmaceutical firms, said on Jan. 3 that the market share of its biosimilar drug Truxima surpassed 35 percent in Europ...
[THE INVESTOR] Popular Korean actress Lee Young-ae has joined a consortium to acquire Cheil General Hospital in Seoul, the first women-specific medical institution which has been virtually closed du...
[THE INVESTOR] Korean biopharmaceutical firm Celltrion said on Jan. 2 that it has registered patents for its autoimmune disease therapeutic antibody biosimilar in over 90 countries. Remsima SC -...
[THE INVESTOR] Hanmi Pharmaceutical said on Dec.28 it has sought approval from the US Food and Drug Administration for Rolontis, its biologic drug for management of chemotherapy-induced neutropenia...
[THE INVESTOR] GC Pharma announced on Dec. 17 it has won approval from the local public health authority to carry out clinical tests on a drug that can be used to treat hemophilia. The drug comp...
Samsung to ramp up Galaxy Fold production
Woongjin defers final bid for Coway to Oct.
Sae-A to acquire fiberboard maker Tailim Packaging
Video-streaming war heats up in S. Korea
YG faces W6b tax penalty as Burning Sun scandal unfolds
Aveva to upgrade integrated industrial software in digital push
Ghost Kitchen secures additional W9.2b
Medytox invests in US startup LifeSprout
September 19, 2019
